Boothbay Fund Management’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-131,600
Closed -$1.51M 1969
2024
Q3
$1.51M Buy
+131,600
New +$1.61M 0.03% 617

Other funds holding ANRO

Boothbay Fund Management's ANRO Position: Q1 2026 in Review

Boothbay Fund Management held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 139,304 shares worth $3.13M. The position accounts for 0.04% of the portfolio, ranked #460.

Boothbay Fund Management first reported a position in ANRO in Q4 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Boothbay Fund Management held 139,304 shares of Alto Neuroscience worth $3.13M as of Q1 2026.
  • Boothbay Fund Management left its Alto Neuroscience share count unchanged in Q1 2026.
  • Alto Neuroscience made up 0.04% of Boothbay Fund Management's portfolio in Q1 2026, its #460 holding.
  • Boothbay Fund Management first reported a position in Alto Neuroscience in Q4 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.